Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease

Subjects with immune-mediated inflammatory diseases (IMID), such as rheumatoid arthritis (RA), have an intrinsic higher probability to develop active-tuberculosis (TB) compared to the general population. The risk ranges from 2.0 to 8.9 in RA patients not receiving therapies. According to the WHO, th...

Full description

Bibliographic Details
Main Authors:	Elisa Petruccioli, Linda Petrone, Teresa Chiacchio, Chiara Farroni, Gilda Cuzzi, Assunta Navarra, Valentina Vanini, Umberto Massafra, Marianna Lo Pizzo, Giuliana Guggino, Nadia Caccamo, Fabrizio Cantini, Fabrizio Palmieri, Delia Goletti
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Immunology
Subjects:	tuberculosis immune-mediated inflammatory disease M. tuberculosis IFN-γ CD27
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.716857/full

Similar Items

Modulation of interferon-gamma response to QuantiFERON-TB-plus detected by enzyme-linked immunosorbent assay in patients with active and latent tuberculosis infection
by: Elisa Petruccioli, et al.
Published: (2016-01-01)

Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit
by: Elisa Petruccioli, et al.
Published: (2016-01-01)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
by: Alessandra Aiello, et al.
Published: (2021-05-01)

Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry
by: Tonino Alonzi, et al.
Published: (2019-06-01)

MiR-21 Is Remotely Governed by the Commensal Bacteria and Impairs Anti-TB Immunity by Down-Regulating IFN-γ
by: Fang Yang, et al.
Published: (2021-01-01)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
by: Germana Grassi, et al.
Published: (2021-04-01)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
by: Elisa Petruccioli, et al.
Published: (2021-06-01)

Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease
by: Valentina Orlando, et al.
Published: (2018-05-01)

Role of Interferon-Gamma (Ifn-γ) in Immune Response Regulation in Hiv-1 and Hiv-1 + Mycobacterium Tuberculosis (Tb) Infected Patients / Interferona-gamma (Ifn-γ) Loma Imūnās Atbildes Regulēšanā Pacientiem Ar HIV-1 un HIV-1 + mycobacterium Tuberculosis
by: Januškevica Inga, et al.
Published: (2016-08-01)

A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette–Guérin-vaccinated Individuals
by: Delfina Peña, et al.
Published: (2015-08-01)

Interferon-Gamma Gene Polymorphism in Patients with Tuberculosis
by: biranvand E, et al.
Published: (2011-04-01)

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis
by: Sally A. Sharpe, et al.
Published: (2012-03-01)

Genome-Wide Gene Expression Analysis of Mtb-Infected DC Highlights the Rapamycin-Driven Modulation of Regulatory Cytokines via the mTOR/GSK-3β Axis
by: Marilena P. Etna, et al.
Published: (2021-04-01)

Toll-Like Receptor 8 Agonist Strengthens the Protective Efficacy of ESAT-6 Immunization to Mycobacterium tuberculosis Infection
by: Jun Tang, et al.
Published: (2018-01-01)

Prevalence of latent tuberculosis infection among coal workers’ pneumoconiosis patients in China: a cross-sectional study
by: Yan Jin, et al.
Published: (2018-04-01)

Tuberculosis biomarkers: from diagnosis to protection
by: Delia Goletti, et al.
Published: (2016-06-01)

Features Immunodiagnostic Local Forms of Tuberculosis in Children
by: E. A. Borodulina, et al.
Published: (2015-08-01)

Malnutrition: Modulator of Immune Responses in Tuberculosis
by: Padmapriyadarsini Chandrasekaran, et al.
Published: (2017-10-01)

Cordyceps sinensis promotes immune regulation and enhances bacteriostatic activity of PA-824 via IL-10 in Mycobacterium tuberculosis disease
by: D.G. Li, et al.

Avaliação de marcadores biológicos com potencial para detecção da evolução para doença em tuberculose
by: Raquel da Silva Corrêa
Published: (2012)

Avaliação de marcadores biológicos com potencial para detecção da evolução para doença em tuberculose
by: Raquel da Silva Corrêa
Published: (2012)

Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis.
by: Teresa ePrezzemolo, et al.
Published: (2014-04-01)

Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa
by: Ansia van Coller, et al.
Published: (2021-09-01)

Utilizzo di nuovi test immunologici nella diagnostica dell’infezione da M. tuberculosis
by: Ilaria Sauzullo, et al.
Published: (2006-12-01)

QuantiFERON® TB GOLD’ s applications in the tuberculosis disease
by: Maria Saladino, et al.
Published: (2014-06-01)

LYMPHOCYTE-T TYPE TH1 AND TH2 ACTIVITY DIFFERENCE OF LUNG TISSUE ON Heligmosomoides polygyrus NEMATODE AND Mycobacterium tuberculosis SEQUENTIAL CO-INFECTION
by: Laksmi Wulandari, et al.
Published: (2017-11-01)

ESAT-6-ELISpot and interferon γ in the diagnosis of pleural tuberculosis
by: Waheed Shouman, et al.
Published: (2012-07-01)

Constitutive expression of SMAR1 confers susceptibility to Mycobacterium tuberculosis infection in a transgenic mouse model
by: Bhawna Yadav, et al.
Published: (2015-01-01)

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
by: Teresa Chiacchio, et al.
Published: (2017-01-01)

Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy
by: Tumaini Nagu, et al.
Published: (2017-03-01)

Immune thrombocytopenia in tuberculosis: Causal or coincidental?
by: Gopalakrishnan Srividya, et al.
Published: (2014-01-01)

Mycobacterium tuberculosis epitope-specific interferon-g production in healthy Brazilians reactive and non-reactive to tuberculin skin test
by: Bosco Christiano Maciel da Silva, et al.
Published: (2014-12-01)

Specifinio imuninio atsako vertinimas diagnozuojant tuberkulioz4s infekciją vaikams
by: Hansted, Edita
Published: (2009)

Regulation of Interferon-γ receptor (IFN-γR) expression in macrophages during Mycobacterium tuberculosis infection
by: Kak Gunjan, et al.
Published: (2020-04-01)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
by: Marco P. La Manna, et al.
Published: (2020-09-01)

Cross-talk between the Immune System and Tuberculosis Pathogenesis; a Review with Emphasis on the Immune Based Treatment
by: Mohammad Reza Javan, et al.
Published: (2016-11-01)

Innate immune receptors in development of Mycobacterium tuberculosis infection
by: A. V. Lapshtaeva, et al.
Published: (2020-04-01)

Predictors for false-negative QuantiFERON-TB Gold assay results in patients with extrapulmonary tuberculosis
by: Youn Jeong Kim, et al.
Published: (2018-09-01)

CXCL10/IP10 is a novel potential in vitro marker of TB infection
by: Ilaria Sauzullo, et al.
Published: (2009-06-01)

QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01)